Skip to main content
. Author manuscript; available in PMC: 2015 Oct 6.
Published in final edited form as: Curr Opin Allergy Clin Immunol. 2012 Oct;12(5):555–563. doi: 10.1097/ACI.0b013e328357ca53

Table 2. Strategies for improving specific immunotherapy.

Strategies Examples References
Molecule-based
Natural molecules Chemical treatment of extracts Depigmented aldehyde-treated extracts
(house dust mite, grass and tree pollen)
[1724]
Synthetic molecules Peptides T-cell peptides of Fel d 1 [15▪]
Recombinant molecules Folding variants Pru p 3 folding variant [27]
Mutants Mus m 1 structural mutant [28]
Fragments/oligomers Art v 1 mutation of disulfide bonds [29]
Hybrids Trimer of Bet v 1 fragment [30]
Fel d 1 with duplicated T-cell epitopes
and disrupting of disulfide bonds
[31]
Feld 1 random mutations [34]
Der p 1–2 hybrid [33]
Peptide-carrier fusion proteins Ole e 1 peptides coupled to KLH [39]
Der p 2 peptides coupled to KLH [40]
Alt a 1 peptides coupled to KLH [41]
Phl p 1 peptides fused to VP1 [43]
Fel d 1 peptides fused to PreS [44▪]
DNA vaccines Der p 2 mutant [47]
Der p 1 mature [48]
Cyn d 1 [49]
RNA vaccines [50]
Routes
Oral Desensitization in food allergy Peanut flour [52]
Edible seeds Rice seeds with shuffled Cry j 2,Der p 1 fragment,
Der f 2 with disrupted disulfide bonds [57]
[5456]
Sublingual Recombinant allergens Natural-like recDer p 2 [58]
Epicutaneaous Pollen extract patches Grass pollen extract [60]
Food allergens Peanut extract [61]
Intralymphatic MAT MAT-Fel d 1 [62▪]
Immunomodulation
Conjugated molecules CpGs Cry j 1-CpG [64]
Vitamin D3 Fel d 1 Vit D3 [66]

KLH, keyhole limpet hemocyanin; MAT, modular antigen transporter.